# US 2021/0274800 A1 · Lactic acid bacteria composition for preparing fermented food products with increased natural sweetness and flavor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0274800 A1
- Document ID: US20210274800A1
- Status: Published application
- Kind: A1
- Application number: 16/497,072
- Filed: 2018-03-21
- Published: 2021-09-09
- Earliest claimed: 2017-03-28
- Assignees: Chr. Hansen A/S
- Applicants: Chr. Hansen A/S
- Inventors: Sonja BLOCH; Gaelle Lettier BUCHHORN
- Web page: https://patentgrep.com/patent/US20210274800A1

## CPC

- A23C 9/1238: {using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus}
- C12N 15/746: {for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)}
- A23C 13/16: containing, or treated with, microorganisms, enzymes, or antibiotics; Sour cream
- A23C 17/02: containing, or treated with, microorganisms or enzymes
- A23C 19/0323: {using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general (using moulds A23C19/0682)}
- A23C 21/026: {containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria}
- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12Y 207/01002: Glucokinase (2.7.1.2)
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2400/11: Lactobacillus
- A23V 2400/249: Thermophilus
- C12R 2001/225: Lactobacillus
- C12R 2001/46: Streptococcus {; Enterococcus; Lactococcus}
- A23C: DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF (preservation thereof A23B11/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention relates to a composition for producing a fermented milk product comprising (i) at least one Streptococcus thermophilus (St) strain, wherein the St strain is galactose-fermenting, wherein the strain carries a mutation in the DNA sequence of the glcK gene encoding a glucokinase protein, wherein the mutation inactivates the glucokinase protein or has a negative effect on expression of the gene, and (ii) at least one Lactobacillus delbrueckii subsp. bulgaricus (Lb) strain, wherein the Lb strain is lactose-deficient and capable of metabolizing a non-lactose carbohydrate.

## Claims

### Claim 1

A composition for producing a fermented milk product comprising:
(i) at least one mutated Streptococcus thermophilus (St) strain, wherein the St strain is galactose-fermenting and carries a mutation in the DNA sequence of the glcK gene encoding a glucokinase protein, wherein the mutation inactivates the glucokinase protein or has a negative effect on expression of the gene, and
(ii) at least one Lactobacillus delbrueckii subsp. bulgaricus (Lb) strain, wherein the Lb strain is lactose-deficient and capable of metabolizing a non-lactose carbohydrate.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the St strain is 2-deoxyglucose resistant.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the St strain carries a mutation that reduces the transport of glucose into the cell.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the St strain increases the amount of glucose in 9.5% B-milk to at least 5 mg/ml when inoculated into the 9.5% B-milk at a concentration of 106-107 CFU/ml and grown at 40° C. for 20 hours.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the St strain increases the amount of glucose in 9.5% B-milk with 0.05% sucrose to at least 5 mg/ml when inoculated into the 9.5% B-milk with 0.05% sucrose at a con-centration of 106-107 CFU/ml and grown at 40° C. for 20 hours.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the Lb strain is capable of metabolizing a non-lactose carbohydrate selected from the group consisting of sucrose, galactose and glucose.

### Claim 7 (depends on 6)

The composition according to claim 6, wherein the Lb strain is capable of metabolizing glucose.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the Lb strain is selected from the group consisting of the strain deposited with DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Inhoffenstr. 7B, D-38124 Braunschweig (DSMZ), under accession number DSM 28910, and mutant strains derived from DSM 28910 that have the ability to generate white colonies on a medium containing lactose and X-Gal.

### Claim 9 (depends on 1)

A composition according to claim 1, wherein the St strain is selected from the group consisting of the Streptococcus thermophilus strain CHCC19216 deposited with DSMZ under accession number DSM 32227, the Streptococcus thermophilus strain CHCC16731 deposited with DSMZ under accession number DSM 28889, the Streptococcus thermophilus strain CHCC15757 deposited with DSMZ under accession number DSM 25850, the Streptococcus thermophilus strain CHCC15887 deposited with DSMZ under accession number DSM 25851, the Streptococcus thermophilus strain CHCC16404 deposited with DSMZ under accession number DSM 26722, and mutant strains derived therefrom using one of the deposited strains as starting material, wherein the mutant strains have a retained or further improved glucose secreting property relative to the deposited strain used as starting material.

### Claim 10 (depends on 1)

A method for producing a fermented milk product comprising inoculating and fermenting a milk substrate with the composition according to claim 1.

### Claim 11 (depends on 1)

A fermented milk product comprising the composition according to claim 1.

### Claim 12

(canceled)

### Claim 13 (depends on 10)

The method according to claim 10, wherein the St strain is 2-deoxyglucose resistant.

### Claim 14 (depends on 10)

The method according to claim 10, wherein the St strain carries a mutation that reduces the transport of glucose into the cell.

### Claim 15 (depends on 10)

The method according to claim 10, wherein the St strain increases the amount of glucose in 9.5% B-milk to at least 5 mg/ml when inoculated into the 9.5% B-milk at a concentration of 106-107 CFU/ml and grown at 40° C. for 20 hours.

### Claim 16 (depends on 10)

The method according to claim 10, wherein the St strain increases the amount of glucose in 9.5% B-milk with 0.05% sucrose to at least 5 mg/ml when inoculated into the 9.5% B-milk with 0.05% sucrose at a con-centration of 106-107 CFU/ml and grown at 40° C. for 20 hours.

### Claim 17 (depends on 10)

The method according to claim 10, wherein the Lb strain is capable of metabolizing a non-lactose carbohydrate selected from the group consisting of sucrose, galactose and glucose.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the Lb strain is capable of metabolizing glucose.

### Claim 19 (depends on 10)

The method according to claim 10, wherein the Lb strain is selected from the group consisting of the strain deposited with DSMZ under accession number DSM 28910, and mutant strains derived from DSM 28910 that have the ability to generate white colonies on a medium containing lactose and X-Gal.

### Claim 20 (depends on 10)

A method according to claim 10, wherein the St strain is selected from the group consisting of the Streptococcus thermophilus strain CHCC19216 deposited with DSMZ under accession number DSM 32227, the Streptococcus thermophilus strain CHCC16731 deposited with DSMZ under accession number DSM 28889, the Streptococcus thermophilus strain CHCC15757 deposited with DSMZ under accession number DSM 25850, the Streptococcus thermophilus strain CHCC15887 deposited with DSMZ under accession number DSM 25851, the Streptococcus thermophilus strain CHCC16404 deposited with DSMZ under accession number DSM 26722, and mutant strains derived therefrom using one of the deposited strains as starting material, wherein the mutant strains have a retained or further improved glucose secreting property relative to the deposited strain used as starting material.
